SNT 6302 is my focus ,, even though they have 4 x Phase II in action all funded till mid 2025,,, yes I could see them raising in December off the back of the SNT 6302 as that will be a High Valued Catalyst...
This is a slightly longer play for me than usual , I'm not after a fixed margin trade here of 20% , have been adding to my holding over the past month.
The Scaring and Burns treatment is a highly visual and easily understood treatment, recruitment is now completed, the Phase I results Principal Investigator Comment Below “SNT-6302 leads directly to an unprecedented change to the scar composition that we have not seen with any other form of treatment.”
Professor Fiona Wood Burns Service of Western Australia Director of the Burn Injury Research Unit University of Western Australia
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)